youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
ACHC:NASDAQ
Acadia Healthcare Company Inc
$29.72
arrow_upward
+0.34%(+0.100) 1D
Nov 3, 12:42:31 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACHC...
Open
$29.96
High
$30.28
Low
$29.67
Mkt. cap
2.77B
Avg. vol.
1.62M
Volume
358.69K
52-wk high
$35.82
52-wk low
$11.43
EPS
-$12.46
Beta
0.64
Shares outstanding
93.10M
No. of employees
22K
Open
$29.96
High
$30.28
Low
$29.67
Mkt. cap
2.77B
Avg. vol.
1.62M
Volume
358.69K
52-wk high
$35.82
52-wk low
$11.43
EPS
-$12.46
Beta
0.64
Shares outstanding
93.10M
No. of employees
22K
News stories
From web sources and news partners
FinancialContent
·
14 hours ago
Acadia Healthcare (ACHC) to report earnings tomorrow: here is what to expect
Profile
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
The company is headquartered in Franklin, Tennessee. As of 2024, Acadia operated over 50 inpatient psychiatric hospitals in 19 U.S. states, including Arizona, Arkansas, Florida, Georgia, Indiana, Michigan, Missouri, New Mexico, Ohio, Oklahoma, Pennsylvania, Tennessee, Utah, and Wisconsin. It is one of the country's largest hospital systems. It also operates, as of 2024, 165 methadone clinics in 33 states, making it the U.S.'s largest methadone-clinic chain.
Acadia was founded as a private corporation in 2005 by Reeve B. Waud and went public in 2011. Wikipedia
About Acadia Healthcare Company Inc
CEOChristopher H. Hunter
Employees22K
Founded2005
Headquarters-
SectorHealth care provider
Websiteacadiahealthcare.com
Analyst ratings
Based on 5 analysts giving stock ratings to ACHC in the past 3 months
Hold
Buy
2
Hold
2
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ACHC in the last 3 months.
Highest
Current $29.72
$40.00 (+34.59%)
Average
$36.00 (+21.13%)
Lowest
$32.00 (+7.67%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Andrew Cooper Raymond James | Buy | Maintained | $39.00 | +31.2% | 09/28/2026 |
Whit Mayo Leerink Partners | Hold | Reiterated | $33.00 | +11% | 09/23/2026 |
Brian Tanquilut Jefferies | Buy | Maintained | $40.00 | +34.6% | 09/17/2026 |
Joanna Gajuk Bank of America Securities | Sell | Maintained | - | - | 09/14/2026 |
Andrew Mok CFA Barclays | Hold | Maintained | $32.00 | +7.7% | 08/28/2026 |
Ben Hendrix RBC Capital | Buy | Maintained | $31.00 | +4.3% | 07/30/2026 |
Jason Cassorla Guggenheim | Buy | Maintained | $39.00 | +31.2% | 07/29/2026 |
Matthew Gillmor CFA KeyBanc | Buy | Maintained | $40.00 | +34.6% | 07/30/2026 |
Ryan Langston TD Cowen | Buy | Reiterated | $36.00 | +21.1% | 07/30/2026 |
Sarah James Cantor Fitzgerald | Hold | Maintained | $30.00 | +0.9% | 07/29/2026 |
A.J. Rice UBS | Buy | Maintained | $39.00 | +31.2% | 07/28/2026 |
Unknown Analyst KeyBanc | Buy | Maintained | $40.00 | +34.6% | 07/14/2026 |
Ann Hynes Mizuho Securities | Hold | Maintained | $31.00 | +4.3% | 07/13/2026 |
John Ransom Raymond James | Buy | Maintained | $39.00 | +31.2% | 05/04/2026 |
Pito Chickering Deutsche Bank | Buy | Maintained | $32.00 | +7.7% | 05/01/2026 |
Gary Taylor TD Cowen | Buy | Reiterated | $30.00 | +0.9% | 04/28/2026 |
Next call in 44:13:08
Thu, Nov 5, 9:00 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.46
Revenue / Est. (USD)
- / 877.85M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 851.57M | 821.46M | 828.80M | 865.84M |
Cost of goods sold | 492.58M | 491.61M | 496.53M | 504.29M |
Cost of revenue | 492.58M | 491.61M | 496.53M | 504.29M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 63.21M | 60.35M | 64.93M | 67.60M |
Operating expense | 239.47M | 282.21M | 248.44M | 273.78M |
Total operating expenses | 732.05M | 773.82M | 744.97M | 778.07M |
Operating income | 119.52M | 47.64M | 83.84M | 87.77M |
Other non operating income | -476.00K | -135.46M | -216.00K | -224.00K |
EBT including unusual items | 39.98M | -1.17B | 10.96M | 22.01M |
EBT excluding unusual items | 82.43M | -125.74M | 45.29M | 49.37M |
Income tax expense | 1.67M | 7.84M | 6.50M | 9.75M |
Effective tax rate | 4.17% | -0.67% | 59.28% | 44.29% |
Other operating expenses | 128.79M | 176.10M | 131.08M | 155.75M |
Net income | 36.25M | -1.18B | 4.10M | 10.93M |
Net profit margin | 4.26% | -143.34% | 0.50% | 1.26% |
Earnings per share | 0.72 | 0.07 | 0.37 | 0.38 |
Interest and investment income | - | - | - | - |
Interest expense | -36.62M | -37.92M | -38.33M | -38.18M |
Net interest expenses | -36.62M | -37.92M | -38.33M | -38.18M |
Depreciation and amortization charges | 47.47M | 45.75M | 52.43M | 50.43M |
EBITDA | 166.99M | 93.40M | 136.26M | 138.20M |
Gain or loss from assets sale | - | - | -1.22M | -2.36M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events